Redox regulation of the VEGF signaling path and tissue vascularization: Hydrogen peroxide, the common link between physical exercise and cutaneous wound healing

Free Radical Biology and Medicine

Volumn 44, Issue 2, 2008, Pages 180-192

  Roy, Sashwati ^a   Khanna, Savita ^a   Sen, Chandan K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Free radicals

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIOXIDANT; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; EXERCISE; HUMAN; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION; WOUND HEALING;

ANIMALS; ANTIOXIDANTS; EXERCISE; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDANTS; OXIDATION-REDUCTION; PHYSICAL CONDITIONING, ANIMAL; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGY; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 37849012181     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.01.025     Document Type: Review

References (180)

1. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
2. Faraci F.M. Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1931-1933
3. Stone J.R., and Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 9 (2002) 231-238
4. Stone J.R., and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signaling 8 (2006) 243-270
5. Tateno K., Minamino T., Miyauchi H., Kunieda T., and Komuro I. Application of hematopoietic cells to therapeutic angiogenesis. Curr. Pharm. Des. 12 (2006) 557-563
6. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., and Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66 (2006) 7843-7848
7. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb. Vasc. Biol. 26 (2006) 1008-1014
8. Li B., Sharpe E.E., Maupin A.B., Teleron A.A., Pyle A.L., Carmeliet P., and Young P.P. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 20 (2006) 1495-1497
9. Rafii S., Meeus S., Dias S., Hattori K., Heissig B., Shmelkov S., Rafii D., and Lyden D. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin. Cell Dev. Biol. 13 (2002) 61-67
10. Zhuang Z.W., Gao L., Murakami M., Pearlman J.D., Sackett T.J., Simons M., and de Muinck E.D. Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents. Radiology 240 (2006) 698-707
11. Heil M., Eitenmuller I., Schmitz-Rixen T., and Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell. Mol. Med. 10 (2006) 45-55
12. Chilian W.M. Editorial comment on Arteriogenesis-Is this terminology necessary?. Basic Res. Cardiol. 98 (2003) 6-7
13. Ji R.C. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat. Res. Biol. 4 (2006) 83-100
14. Connolly D.T., Olander J.V., Heuvelman D., Nelson R., Monsell R., Siegel N., Haymore B.L., Leimgruber R., and Feder J. Human vascular permeability factor: isolation from U937 cells. J. Biol. Chem. 264 (1989) 20017-20024
15. Robinson C.J., Mulloy B., Gallagher J.T., and Stringer S.E. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281 (2006) 1731-1740
16. Cai J., Jiang W.G., Ahmed A., and Boulton M. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc. Res. 71 (2006) 20-31
17. Witmer A.N., van Blijswijk B.C., Dai J., Hofman P., Partanen T.A., Vrensen G.F., and Schlingemann R.O. VEGFR-3 in adult angiogenesis. J. Pathol. 195 (2001) 490-497
18. Tepper O.M., Capla J.M., Galiano R.D., Ceradini D.J., Callaghan M.J., Kleinman M.E., and Gurtner G.C. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105 (2005) 1068-1077
19. +stem cells into the expanding tumor vasculature. Int. J. Cancer 119 (2006) 839-846
20. Crottogini A., Meckert P.C., Vera Janavel G., Lascano E., Negroni J., Del Valle H., Dulbecco E., Werba P., Cuniberti L., Martinez V., De Lorenzi A., Telayna J., Mele A., Fernandez J.L., Marangunich L., Criscuolo M., Capogrossi M.C., and Laguens R. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum. Gene Ther. 14 (2003) 1307-1318
21. Lloyd P.G., Prior B.M., Li H., Yang H.T., and Terjung R.L. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H759-H768
22. Yu J., deMuinck E.D., Zhuang Z., Drinane M., Kauser K., Rubanyi G.M., Qian H.S., Murata T., Escalante B., and Sessa W.C. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10999-11004
23. Zaccagnini G., Gaetano C., Della Pietra L., Nanni S., Grasselli A., Mangoni A., Benvenuto R., Fabrizi M., Truffa S., Germani A., Moretti F., Pontecorvi A., Sacchi A., Bacchetti S., Capogrossi M.C., and Farsetti A. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J. Biol. Chem. 280 (2005) 14790-14798
24. Achen M.G., Mann G.B., and Stacker S.A. Targeting lymphangiogenesis to prevent tumour metastasis. Br. J. Cancer 94 (2006) 1355-1360
25. Bando H., Weich H.A., Horiguchi S., Funata N., Ogawa T., and Toi M. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Oncol. Rep. 15 (2006) 653-659
26. Ding M.X., Lin X.Q., Fu X.Y., Zhang N., and Li J.C. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma. World J. Gastroenterol. 12 (2006) 4582-4585
27. Yang J., Wu H.F., Qian L.X., Zhang W., Hua L.X., Yu M.L., Wang Z., Xu Y.G., and Sui X.R. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression. Asian J. Androl. 8 (2006) 169-175
28. Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1402-H1410
29. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., Chou C.H., Jeng Y.M., Wang M.Y., Chang K.J., Hung M.C., and Kuo M.L. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
30. Wang J.F., Zhang X., and Groopman J.E. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. J. Biol. Chem. 279 (2004) 27088-27097
31. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312 (2006) 549-560
32. Saaristo A., Tammela T., Farkkila A., Karkkainen M., Suominen E., Yla-Herttuala S., and Alitalo K. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169 (2006) 1080-1087
33. Cudmore M., Ahmad S., Al-Ani B., Hewett P., Ahmed S., and Ahmed A. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem. Biophys. Res. Commun. 345 (2006) 1275-1282
34. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., and DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152 (1998) 1445-1452
35. Allen D.B., Maguire J.J., Mahdavian M., Wicke C., Marcocci L., Scheuenstuhl H., Chang M., Le A.X., Hopf H.W., and Hunt T.K. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch. Surg. 132 (1997) 991-996
36. Gordillo G.M., and Sen C.K. Revisiting the essential role of oxygen in wound healing. Am. J. Surg. 186 (2003) 259-263
37. Chang N., Goodson F., Gottrup W.H.d., and Hunt T.K. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann. Surg. 197 (1983) 470-478
38. Pai M.P., and Hunt T.K. Effect of varying oxygen tensions on healing of open wounds. Surg. Gynecol. Obstet. 135 (1972) 756-758
39. Howdieshell T.R., Riegner C., Gupta V., Callaway D., Grembowicz K., Sathyanarayana, and McNeil P.L. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann. Surg. 228 (1998) 707-715
40. Roth D., Piekarek M., Paulsson M., Christ H., Krieg T., Bloch W., Davidson J.M., and Eming S.A. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am. J. Pathol. 168 (2006) 670-684
41. Straino S., Germani A., Di Carlo A., Porcelli D., De Mori R., Mangoni A., Napolitano M., Martelli F., Biglioli P., and Capogrossi M.C. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110 (2004) 3341-3348
42. Zwaginga J.J., and Doevendans P. Stem cell-derived angiogenic/vasculogenic cells: possible therapies for tissue repair and tissue engineering. Clin. Exp. Pharmacol. Physiol. 30 (2003) 900-908
43. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., and Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156 (2000) 1499-1504
44. Bloor C.M. Angiogenesis during exercise and training. Angiogenesis 8 (2005) 263-271
45. Kojda G., and Hambrecht R. Molecular mechanisms of vascular adaptations to exercise: physical activity as an effective antioxidant therapy?. Cardiovasc. Res. 67 (2005) 187-197
46. Prior B.M., Yang H.T., and Terjung R.L. What makes vessels grow with exercise training?. J. Appl. Physiol. 97 (2004) 1119-1128
47. Prior B.M., Lloyd P.G., Yang H.T., and Terjung R.L. Exercise-induced vascular remodeling. Exerc. Sport Sci. Rev. 31 (2003) 26-33
48. Gu J.W., Shparago M., Tan W., and Bailey A.P. Tissue endostatin correlates inversely with capillary network in rat heart and skeletal muscles. Angiogenesis 9 (2006) 93-99
49. Gustafsson T., Ameln H., Fischer H., Sundberg C.J., Timmons J.A., and Jansson E. VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J. Appl. Physiol. 98 (2005) 2137-2146
50. Yao Z., Lafage-Proust M.H., Plouet J., Bloomfield S., Alexandre C., and Vico L. Increase of both angiogenesis and bone mass in response to exercise depends on VEGF. J. Bone Miner. Res. 19 (2004) 1471-1480
51. Brown M.D., and Hudlicka O. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6 (2003) 1-14
52. Frisbee J.C., Balch Samora J., Peterson J., and Bryner R. Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H2483-H2492
53. Suzuki J. l-Arginine supplementation causes additional effects on exercise-induced angiogenesis and VEGF expression in the heart and hind-leg muscles of middle-aged rats. J. Physiol. Sci. 56 (2006) 39-44
54. Suzuki J. Microvascular angioadaptation after endurance training with l-arginine supplementation in rat heart and hindleg muscles. Exp. Physiol. 90 (2005) 763-771
55. Momken I., Lechene P., Ventura-Clapier R., and Veksler V. Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H914-H920
56. Gigante B., Tarsitano M., Cimini V., De Falco S., and Persico M.G. Placenta growth factor is not required for exercise-induced angiogenesis. Angiogenesis 7 (2004) 277-284
57. Jensen L., Bangsbo J., and Hellsten Y. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J. Physiol. 557 (2004) 571-582
58. Steiner S., Niessner A., Ziegler S., Richter B., Seidinger D., Pleiner J., Penka M., Wolzt M., Huber K., Wojta J., Minar E., and Kopp C.W. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181 (2005) 305-310
59. Rehman J., Li J., Parvathaneni L., Karlsson G., Panchal V.R., Temm C.J., Mahenthiran J., and March K.L. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J. Am. Coll. Cardiol. 43 (2004) 2314-2318
60. Prior S.J., Hagberg J.M., Paton C.M., Douglass L.W., Brown M.D., McLenithan J.C., and Roth S.M. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1848-H1855
61. Gavin T.P., Westerkamp L.M., and Zwetsloot K.A. Soleus, plantaris and gastrocnemius VEGF mRNA responses to hypoxia and exercise are preserved in aged compared with young female C57BL/6 mice. Acta Physiol. (Oxford) 188 (2006) 113-121
62. Waters R.E., Rotevatn S., Li P., Annex B.H., and Yan Z. Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 287 (2004) C1342-C1348
63. Tang K., Breen E.C., Gerber H.P., Ferrara N.M., and Wagner P.D. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol. Genomics 18 (2004) 63-69
64. Kivela R., Silvennoinen M., Touvra A.M., Lehti T.M., Kainulainen H., and Vihko V. Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 20 (2006) 1570-1572
65. Iemitsu M., Maeda S., Jesmin S., Otsuki T., and Miyauchi T. Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1290-H1298
66. Ding Y.H., Luan X.D., Li J., Rafols J.A., Guthinkonda M., Diaz F.G., and Ding Y. Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Curr. Neurovasc. Res. 1 (2004) 411-420
67. Xue M., Le N.T., and Jackson C.J. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin. Ther. Targets 10 (2006) 143-155
68. Sen C.K. The general case for redox control of wound repair. Wound Repair Regen. 11 (2003) 431-438
69. Harrison D.G., Widder J., Grumbach I., Chen W., Weber M., and Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J. Intern. Med. 259 (2006) 351-363
70. In: Sen C.K., Hanninen O., and Packer L. (Eds). Handbook of oxidants and antioxidants in exercise. (2000), Amsterdam, Elsevier 1-1191
71. Majno G. Chronic inflammation: links with angiogenesis and wound healing. Am. J. Pathol. 153 (1998) 1035-1039
72. Naldini A., and Carraro F. Role of inflammatory mediators in angiogenesis. Curr. Drug Targets Inflammation Allergy 4 (2005) 3-8
73. Moldovan L., and Moldovan N.I. Role of monocytes and macrophages in angiogenesis. EXS (2005) 127-146
74. Crivellato E., and Ribatti D. Involvement of mast cells in angiogenesis and chronic inflammation. Curr. Drug Targets Inflammation Allergy 4 (2005) 9-11
75. Zheng Y., Murakami M., Takahashi H., Yamauchi M., Kiba A., Yamaguchi S., Yabana N., Alitalo K., and Shibuya M. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2019-2026
76. Yamaji-Kegan K., Su Q., Angelini D.J., Champion H.C., and Johns R.A. Hypoxia-induced mitogenic factor has pro-angiogenic and pro-inflammatory effects in the lung via VEGF and VEGF receptor-2. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L1159-L1168
77. Rajashekhar G., Willuweit A., Patterson C.E., Sun P., Hilbig A., Breier G., Helisch A., and Clauss M. Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J. Vasc. Res. 43 (2006) 193-204
78. Pousa I.D., Gisbert J.P., and Mate J. Vascular development in inflammatory bowel disease. Gastroenterol. Hepatol. 29 (2006) 414-422
79. Koutroubakis I.E., Tsiolakidou G., Karmiris K., and Kouroumalis E.A. Role of angiogenesis in inflammatory bowel disease. Inflammatory Bowel Dis. 12 (2006) 515-523
80. Buschmann I., Heil M., Jost M., and Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10 (2003) 371-379
81. Duda D.G., Fukumura D., and Jain R.K. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol. Med. 10 (2004) 143-145
82. Murphy M.O., Ghosh J., Fulford P., Khwaja N., Halka A.T., Carter A., Turner N.J., and Walker M.G. Expression of growth factors and growth factor receptor in non-healing and healing ischaemic ulceration. Eur. J. Vasc. Endovasc. Surg. 31 (2006) 516-522
83. Dvorak H.F. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24 (2000) 75-78
84. Luscinskas F.W., and Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8 (1994) 929-938
85. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
86. Karpanen T., and Makinen T. Regulation of lymphangiogenesis and mdash;from cell fate determination to vessel remodeling. Exp. Cell Res. 312 (2006) 575-583
87. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., Jeltsch M., Petrova T.V., Pytowski B., Stacker S.A., Yla-Herttuala S., Jackson D.G., Alitalo K., and McDonald D.M. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 (2005) 247-257
88. Van der Auwera I., Van Laere S.J., Van den Eynden G.G., Benoy I., van Dam P., Colpaert C.G., Fox S.B., Turley H., Harris A.L., Van Marck E.A., Vermeulen P.B., and Dirix L.Y. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin. Cancer Res. 10 (2004) 7965-7971
89. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., Jessberger R., Merad M., and Randolph G.J. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24 (2006) 203-215
90. Roy S., Khanna S., Nallu K., Hunt T.K., and Sen C.K. Dermal wound healing is subject to redox control. Mol. Ther. 13 (2006) 211-220
91. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., and Shah A.M. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signaling 8 (2006) 691-728
92. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71 (2006) 226-235
93. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
94. Cheng Y., and Song C. Hydrogen peroxide homeostasis and signaling in plant cells. Sci. China C Life Sci. 49 (2006) 1-11
95. Gechev T.S., and Hille J. Hydrogen peroxide as a signal controlling plant programmed cell death. J. Cell Biol. 168 (2005) 17-20
96. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3 (2002) 1129-1134
97. Neill S., Desikan R., and Hancock J. Hydrogen peroxide signalling. Curr. Opin. Plant Biol. 5 (2002) 388-395
98. Rhee S.G., Bae Y.S., Lee S.R., and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000 (2000) PE1
99. Jones R.D., and Morice A.H. Hydrogen peroxide and mdash;an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction. Pharmacol. Ther. 88 (2000) 153-161
100. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
101. Sen C.K. Antioxidant and redox regulation of cellular signaling: introduction. Med. Sci. Sports Exerc. 33 (2001) 368-370
102. Sen C.K. Cellular thiols and redox-regulated signal transduction. Curr. Top. Cell Regul. 36 (2000) 1-30
103. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., Cohen C., Moses M., Kilroy S., Arnold R.S., and Lambeth J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 715-720
104. Sen C.K., Khanna S., Gordillo G., Bagchi D., Bagchi M., and Roy S. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann. N.Y. Acad. Sci. 957 (2002) 239-249
105. Jackson S.J., and Venema R.C. Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J. Nutr. 136 (2006) 1178-1184
106. Cho M., Hunt T.K., and Hussain M.Z. Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2357-H2363
107. Jackson I.L., Batinic-Haberle I., Sonveaux P., Dewhirst M.W., and Vujaskovic Z. ROS production and angiogenic regulation by macrophages in response to heat therapy. Int. J. Hyperthermia 22 (2006) 263-273
108. Atalay M., Lappalainen J., and Sen C.K. Dietary antioxidants for the athlete. Curr. Sports Med. Rep. 5 (2006) 182-186
109. Sen C.K., and Packer L. Thiol homeostasis and supplements in physical exercise. Am. J. Clin. Nutr. 72 (2000) 653S-669S
110. Sen C.K. Oxidants and antioxidants in exercise. J. Appl. Physiol. 79 (1995) 675-686
111. Polytarchou C., and Papadimitriou E. Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic. Res. 38 (2004) 501-508
112. Monte M., Davel L.E., and de Lustig E.S. Inhibition of lymphocyte-induced angiogenesis by free radical scavengers. Free Radic. Biol. Med. 17 (1994) 259-266
113. Schwartz J.L., and Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr. Cancer 26 (1996) 229-236
114. Sasaki H., Zhu L., Fukuda S., and Maulik N. Inhibition of NF kappa B activation by pyrrolidine dithiocarbamate prevents in vivo hypoxia/reoxygenation-mediated myocardial angiogenesis. Int. J. Tissue React. 22 (2000) 93-100
115. 2+in oxidant-induced NF-kappa B activation. FEBS Lett. 385 (1996) 58-62
116. Marikovsky M. Thiram inhibits angiogenesis and slows the development of experimental tumours in mice. Br. J. Cancer 86 (2002) 779-787
117. Lu J., and Jiang C. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Nutr. Cancer 40 (2001) 64-73
118. McCarty M.F. Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness. Med. Hypotheses 50 (1998) 511-514
119. Shklar G. Mechanisms of cancer inhibition by anti-oxidant nutrients. Oral Oncol. 34 (1998) 24-29
120. Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., El Bedoui J., Chataigneau M., and Schini-Kerth V.B. Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 500 (2004) 299-313
121. Kanadaswami C., Lee L.T., Lee P.P., Hwang J.J., Ke F.C., Huang Y.T., and Lee M.T. The antitumor activities of flavonoids. In Vivo 19 (2005) 895-909
122. Schindler R., and Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 136 (2006) 1477-1482
123. Atalay M., Gordillo G., Roy S., Rovin B., Bagchi D., Bagchi M., and Sen C.K. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett. 544 (2003) 252-257
124. Roy S., Khanna S., Alessio H.M., Vider J., Bagchi D., Bagchi M., and Sen C.K. Anti-angiogenic property of edible berries. Free Radic. Res. 36 (2002) 1023-1031
125. Kim J.D., Liu L., Guo W., and Meydani M. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J. Nutr. Biochem. 17 (2006) 165-176
126. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 25-54
127. Camouse M.M., Hanneman K.K., Conrad E.P., and Baron E.D. Protective effects of tea polyphenols and caffeine. Expert Rev. Anticancer Ther. 5 (2005) 1061-1068
128. Lin M.T., Yen M.L., Lin C.Y., and Kuo M.L. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol. Pharmacol. 64 (2003) 1029-1036
129. Pezzuto J.M. Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol. Ther. 3 (2004) 889-890
130. Weber W.M., Hunsaker L.A., Abcouwer S.F., Deck L.M., and Vander Jagt D.L. Anti-oxidant activities of curcumin and related enones. Bioorg. Med. Chem. 13 (2005) 3811-3820
131. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
132. Kapiotis S., Hermann M., Held I., Seelos C., Ehringer H., and Gmeiner B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2868-2874
133. Lamartiniere, C.A. Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr. 71:1705S-1707S; discussion 1708S-1709S; 2000.
134. Kurzer M.S., and Xu X. Dietary phytoestrogens. Annu. Rev. Nutr. 17 (1997) 353-381
135. Nishimura G., Yanoma S., Mizuno H., Kawakami K., and Tsukuda M. An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Jpn. J. Cancer Res. 90 (1999) 1224-1230
136. Woodson K., Triantos S., Hartman T., Taylor P.R., Virtamo J., and Albanes D. Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res. 22 (2002) 375-378
137. Ashino H., Shimamura M., Nakajima H., Dombou M., Kawanaka S., Oikawa T., Iwaguchi T., and Kawashima S. Novel function of ascorbic acid as an angiostatic factor. Angiogenesis 6 (2003) 259-269
138. Nespereira B., Perez-Ilzarbe M., Fernandez P., Fuentes A.M., Paramo J.A., and Rodriguez J.A. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. Atherosclerosis 171 (2003) 67-73
139. Cecarini V., Gee J., Fioretti E., Amici M., Angeletti M., Eleuteri A.M., and Keller J.N. Protein oxidation and cellular homeostasis: emphasis on metabolism. Biochim. Biophys. Acta 1773 (2007) 93-104
140. Poppek D., and Grune T. Proteasomal defense of oxidative protein modifications. Antioxid. Redox Signaling 8 (2006) 173-184
141. Gitay-Goren H., Cohen T., Tessler S., Soker S., Gengrinovitch S., Rockwell P., Klagsbrun M., Levi B.Z., and Neufeld G. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J. Biol. Chem. 271 (1996) 5519-5523
142. Gengrinovitch S., Berman B., David G., Witte L., Neufeld G., and Ron D. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274 (1999) 10816-10822
143. Maulik N. Redox regulation of vascular angiogenesis. Antioxid. Redox Signaling 4 (2002) 783-784
144. Sauer H., Bekhite M.M., Hescheler J., and Wartenberg M. Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. Exp. Cell Res. 304 (2005) 380-390
145. Sen C.K., Khanna S., Babior B.M., Hunt T.K., Ellison E.C., and Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277 (2002) 33284-33290
146. Schafer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., and Hocker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem. 278 (2003) 8190-8198
147. Kosmidou I., Xagorari A., Roussos C., and Papapetropoulos A. Reactive oxygen species stimulate VEGF production from C(2)C(12) skeletal myotubes through a PI3K/Akt pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 280 (2001) L585-L592
148. Feliers D., Gorin Y., Ghosh-Choudhury G., Abboud H.E., and Kasinath B.S. Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am. J. Physiol. Renal Physiol. 290 (2006) F927-F936
149. Kim Y.M., Kim K.E., Koh G.Y., Ho Y.S., and Lee K.J. Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis. Cancer Res. 66 (2006) 6167-6174
150. Sreekumar P.G., Kannan R., de Silva A.T., Burton R., Ryan S.J., and Hinton D.R. Thiol regulation of vascular endothelial growth factor-A and its receptors in human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 346 (2006) 1200-1206
151. Lee K.S., Kim S.R., Park S.J., Park H.S., Min K.H., Lee M.H., Jin S.M., Jin G.Y., Yoo W.H., and Lee Y.C. Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am. J. Respir. Cell Mol. Biol. 35 (2006) 190-197
152. Khanna S., Roy S., Bagchi D., Bagchi M., and Sen C.K. Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. Free Radic. Biol. Med. 31 (2001) 38-42
153. Sen C.K., Khanna S., Venojarvi M., Trikha P., Ellison E.C., Hunt T.K., and Roy S. Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1821-H1827
154. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., Kim R.Y., Rohan R.M., Colby K.A., Yeo K.T., and Adamis A.P. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98 (1996) 1667-1675
155. Huang S.S., and Zheng R.L. Biphasic regulation of angiogenesis by reactive oxygen species. Pharmazie 61 (2006) 223-229
156. 2. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1395-H1401
157. Salomonsson L., Svensson L., Pettersson S., Wiklund O., and Ohlsson B.G. Oxidised LDL decreases VEGFR-1 expression in human monocyte-derived macrophages. Atherosclerosis 169 (2003) 259-267
158. Chen K., Thomas S.R., Albano A., Murphy M.P., and Keaney Jr. J.F. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J. Biol. Chem. 279 (2004) 35079-35086
159. Maulik N. Redox signaling of angiogenesis. Antioxid. Redox Signaling 4 (2002) 805-815
160. Aslan M., and Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid. Redox Signaling 5 (2003) 781-788
161. Maulik N. Reactive oxygen species drives myocardial angiogenesis?. Antioxid. Redox Signaling 8 (2006) 2161-2168
162. Zhou Q., Liu L.Z., Fu B., Hu X., Shi X., Fang J., and Jiang B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1{alpha} expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 28 (2007) 28-37
163. Gao N., Ding M., Zheng J.Z., Zhang Z., Leonard S.S., Liu K.J., Shi X., and Jiang B.H. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277 (2002) 31963-31971
164. Patel V., Chivukula I.V., Roy S., Khanna S., He G., Ojha N., Mehrotra A., Dias L.M., Hunt T.K., and Sen C.K. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid. Redox Signaling 7 (2005) 1377-1387
165. Matsubara T., and Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J. Immunol. 137 (1986) 3295-3298
166. Abid M.R., Tsai J.C., Spokes K.C., Deshpande S.S., Irani K., and Aird W.C. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J. 15 (2001) 2548-2550
167. Wang Z., Castresana M.R., and Newman W.H. Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 285 (2001) 669-674
168. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., and Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277 (2002) 3101-3108
169. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., Quinn M.T., Pagano P.J., Johnson C., and Alexander R.W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91 (2002) 1160-1167
170. Yamaoka-Tojo M., Ushio-Fukai M., Hilenski L., Dikalov S.I., Chen Y.E., Tojo T., Fukai T., Fujimoto M., Patrushev N.A., Wang N., Kontos C.D., Bloom G.S., and Alexander R.W. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ. Res. 95 (2004) 276-283
171. Ikeda S., Ushio-Fukai M., Zuo L., Tojo T., Dikalov S., Patrushev N.A., and Alexander R.W. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96 (2005) 467-475
172. Tojo T., Ushio-Fukai M., Yamaoka-Tojo M., Ikeda S., Patrushev N., and Alexander R.W. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111 (2005) 2347-2355
173. Wojciak-Stothard B., Tsang L.Y., and Haworth S.G. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (2005) L749-L760
174. Abid M.R., Schoots I.G., Spokes K.C., Wu S.Q., Mawhinney C., and Aird W.C. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J. Biol. Chem. 279 (2004) 44030-44038
175. -/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J. 20 (2006) 970-972
176. Raijmakers M.T., Burton G.J., Jauniaux E., Seed P.T., Peters W.H., Steegers E.A., and Poston L. Placental NAD(P)H oxidase mediated superoxide generation in early pregnancy. Placenta 27 (2006) 158-163
177. Morabito A., De Maio E., Di Maio M., Normanno N., and Perrone F. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions. Oncologist 11 (2006) 753-764
178. Bhisitkul R.B. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br. J. Ophthalmol. 90 (2006) 1542-1547
179. Shams N., and Ianchulev T. Role of vascular endothelial growth factor in ocular angiogenesis. Ophthalmol. Clin. North Am. 19 (2006) 335-344
180. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., and Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652